Avanos Medical to Be Acquired for $1.27 Billion
The medical technology company has agreed to be acquired by American Industrial Partners in an all-cash deal.
The medical technology company has agreed to be acquired by American Industrial Partners in an all-cash deal.
Revised guidance aligns with quality management system regulation changes and provides recommendations for cyber device submissions under section 524B of the FD&C Act.
The postmarket trial is designed to evaluate the performance of a surgical robotic system in free flap reconstruction and lymphatic repair procedures.
The medical technology company has agreed to be acquired by American Industrial Partners in an all-cash deal.
The automated insulin delivery system is now approved for adults with type 2 diabetes and cleared for interoperability with Abbott’s Instinct sensor for type 1 diabetes.
Read MoreWhy HTM teams must treat “old but working” as a high-stakes cyber risk—and how to protect patients and operations now.
Read MoreThe permanent injunction prohibits Biosense Webster from using ‘kill switches’ and tying clinical support to new device purchases, a practice the court found blocked hospital access to lower-cost reprocessed cardiac catheters.
Read MoreThe new portable systems are designed for a range of clinical applications and feature artificial intelligence and advanced imaging functionalities.
Read MoreThe investment will expand facilities in Pennsylvania and Minnesota to increase production of AI-enabled ultrasound and image-guided therapy systems.
Read MoreThe company has now accumulated over 100 authorizations for artificial intelligence in its medical technology portfolio.
Read More
Boston Scientific’s Endotak Reliance leads with ePTFE-coated coils may reduce shock efficacy due to coil calcification.